MSIP and NYEE Launch iLABS, Featuring the Latest Technology in Ophthalmic Care
The inaugural iLABS event took place on September 19, showcasing the latest technologies in ophthalmology from Mount Sinai Health System innovators. Hosted by the Mount Sinai Department of Ophthalmology, the New York Eye and Ear (NYEE) Infirmary Program for Innovation and Technology, and Mount Sinai Innovation Partners (MSIP), iLABS featured the cutting-edge science that is paving the way for new solutions in eye care.
Researchers presented discoveries and concepts on commercial success to a room full of fellow thought leaders, startup founders, investors, and potential partners, with the overarching goal of driving forward technology to help the patient population.
“This is a place where you can come and share ideas,” said Sean Ianchulev, MD, Director, Technology and Innovation, NYEE. “We have great talent here at Mount Sinai, and it’s great to see different perspectives: iLABS will bring together companies and catalysts who can offer information about resources at both Mount Sinai and the local area.” Speakers covered a wide range of topics in ophthalmology, including virtual reality, micro-robotic, artificial intelligence for retinal diagnosis, and more.
Following the presentations, attendees participated in an engaging feedback session and interacted with the innovators at a reception. The event inspired enlightening conversations and insightful ideas, the first in a themed series that will cover Mount Sinai’s various departments.
“iLABS represents Mount Sinai’s commitment to fostering innovation and supporting commercially-relevant translational discoveries for patient benefit,” said Erik Lium, PhD, Executive Vice President, Mount Sinai Innovation Partners. “We look forward to expanding iLABS across the Mount Sinai Health System.”
To learn more about future iLABS and innovation news at Mount Sinai, sign up for the MSIP newsletter.
